Healthcare
Bayer selects Ohio for $2.2 billion pharmaceutical manufacturing campus
The project is expected to create about 600 jobs and draw on a state-backed training center set to open in 2027, linking one of Ohio’s largest biomanufacturing commitments to a workforce strategy designed to prepare operators and technicians before production begins in 2031.